LivaNova (LIVN) Share-based Compensation Growth (5y) (2021 - 2026)
LivaNova (LIVN) Share-based Compensation Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.23% |
| Mar 31, 2026 | -2.81% |
| Dec 31, 2025 | 15.30% |
| Sep 30, 2025 | -15.24% |
| Jun 30, 2025 | -19.04% |
| Mar 31, 2025 | -2.96% |
| Dec 31, 2024 | 51.14% |
| Sep 30, 2024 | 78.75% |
| Jun 30, 2024 | 49.23% |
| Mar 31, 2024 | 17.29% |
| Dec 31, 2023 | 39.61% |
| Sep 30, 2023 | -30.60% |
| Jun 30, 2023 | -10.77% |
| Mar 31, 2023 | -25.08% |
| Dec 31, 2022 | 26.28% |
| Sep 30, 2022 | 13.53% |
| Jun 30, 2022 | 19.51% |
| Mar 31, 2022 | 21.69% |
| Dec 31, 2021 | 20.12% |
| Sep 30, 2021 | 18.46% |